Virogin Biotech (Shanghai) Ltd.

Chine

Commandez votre montre hebdomadaire Virogin Biotech (Shanghai) Ltd.
Quantité totale PI 17
Rang # Quantité totale PI 90 276
Note d'activité PI 2,4/5.0    31
Rang # Activité PI 24 569

Brevets

Marques

1 0
0 0
16 0
0
 
Dernier brevet 2025 - Recombinant oncolytic herpes vir...
Premier brevet 2021 - Multivalent recombinant ace2 and...

Derniers inventions, produits et services

2024 Invention Lipid compound and lipid nanoparticle composition. Provided herein is a lipid compound that can b...
Invention Self-amplifying nucleic acid molecule and use thereof. The present invention relates to an alphav...
Invention Homologous and heterologous therapeutic vaccination strategies for cancer treatment. Compositions...
Invention Nucleic acid molecule, kit and method for detecting monkey pox virus. A nucleic acid molecule, ki...
Invention Self-replicating messenger ribonucleic acid vaccine. A messenger ribonucleic acid (mRNA) molecule...
2023 Invention Methods and device for preparing nucleic acid-encapsulation body complex. Provided in the present...
Invention Recombinant oncolytic herpes virus having an oxygen dependent degradation domain. Provided herein...
Invention Messenger ribonucleic acid vaccine against poxvirus. The present invention relates to an anti-pox...
Invention Combination of recombinant oncolytic virus and checkpoint inhibitor for the treatment of cancer. ...
Invention Transcriptional and translational dual regulated oncolytic herpes simplex virus vectors. An HSV ...
Invention A novel mrna vaccine for the treatment and prevention of hpv-associated lesions and tumors. Immun...
2022 Invention Transcriptional and translational dual regulated oncolytic herpes simplex virus vectors. An HSV v...
2021 Invention Multivalent recombinant ace2 and uses thereof. Recombinant multivalent proteins are provided havi...